MET and ovarian cancer: We have addressed the effect of HGF, and subsequent inhibition of c-MET, on migration of ovarian cancer cells in both directional (chemotactic) and random migration assays, to more accurately recapitulate the environment and proteins encountered in an in vivo setting.